B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients

BackgroundVaccination is considered as most efficient strategy in controlling SARS-CoV-2 pandemic spread. Nevertheless, patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX) are at increased risk to fail humoral and cellular responses upon vaccination. The ability to pre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ana-Luisa Stefanski, Hector Rincon-Arevalo, Eva Schrezenmeier, Kirsten Karberg, Franziska Szelinski, Jacob Ritter, Yidan Chen, Bernd Jahrsdörfer, Carolin Ludwig, Hubert Schrezenmeier, Andreia C. Lino, Thomas Dörner
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2022-04-01
Col·lecció:Frontiers in Immunology
Matèries:
RTX (rituximab)
B-cells
vaccination
SARS – CoV – 2
prediction
Accés en línia:https://www.frontiersin.org/articles/10.3389/fimmu.2022.822885/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars